$NHC

HASSAN EMIL E sold $1.2M of NHC

HASSAN EMIL E sold 5,937 shares of NATIONAL HEALTHCARE CORP (NHC) at $200.00 ($1.19M total) on 2026-06-22.

Original reporting
SEC EDGAR · HASSAN EMIL E
Published Jun 23, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:46 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NHC
Neutral
medium confidence
Mentioned
$NHC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NHCNeutralLow
01

Why it matters

The only new information is the director’s open-market sale size, price, and post-transaction holdings; no operational updates are provided.

02

Market read

Traders may monitor insider activity for sentiment, but this specific filing does not introduce new guidance, contracts, or regulatory developments.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which can increase interpretive sensitivity, but the article still lacks context on motives or future trading intentions.

Relevance 6/10Novelty 4/10Timing: filed 2026-06-23, transaction dated 2026-06-22

Background

The article is a SEC Form 4 insider transaction disclosure for National Healthcare Corp (NHC).

Company-level read

Ticker impact

$NHCNeutralMedium confidence
Context

Form 4 shows director Hassan Emil E sold 5,937 shares at $200/share for about $1.19M, reducing direct holdings to 65,595.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically modest for routine Form 4 sales.

Evidence & confidence

The disclosure is primary-source and time-stamped, but it is an insider sale without accompanying operational or financial catalysts, and there is no 10b5-1 plan stated.

Market effects

None indicated; this is a single-company insider transaction with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

The sale could be unrelated to fundamentals (taxes, diversification, personal liquidity), so it may not signal deterioration.

Key entities

  • NHC

    National Healthcare Corp, the company whose director transaction is disclosed.

  • Hassan Emil E

    Director who sold 5,937 shares at $200/share on 2026-06-22.

Related articles

$NHCLow

NATIONAL HEALTHCARE CORP (NHC): Completion of Acquisition or Disposition of Assets

NATIONAL HEALTHCARE CORP (NHC) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.2 3 ex_983366.htm EXHIBIT 10.2 ex_983366.htm Exhibit 10.2 PARTIAL MASTER LEASE TERMINATION AGREEMENT AND PARTIAL ASSIGNMENT AND ASSUMPTION OF MASTER LEASE This Partial Master Lease Termination Agreement and Partial Assignment and Assumption of Master Lease (this “ Agreement

$NHCHighAI 9/10

ASX Coal Stocks Jump as China Accident Sparks Supply Concerns

Australian coal stocks rose sharply after a deadly explosion at China’s Liushenyu mine in Shanxi raised concerns about tighter coking coal supply. Whitehaven Coal gained 8.7%, Yancoal 7.5% and New Hope 4.7%, outpacing the ASX 200, as Chinese coking coal futures jumped nearly 8% to their limit. The accident killed at least 82 miners, and China ordered a safety investigation.